| DOI | Resolve DOI: https://doi.org/10.1016/S0145-2126(97)00060-X |
|---|
| Author | Search for: Liu, Kan-Zhi1; Search for: Schultz, Christian P.1; Search for: Johnston, James B.; Search for: Lee, Kristine; Search for: Mantsch, Henry H.1 |
|---|
| Affiliation | - National Research Council of Canada. NRC Institute for Biodiagnostics
|
|---|
| Format | Text, Article |
|---|
| Subject | Chronic lymphocytic leukemia; chlorambucil; cladribine (2-chlorodeoxyadenosine); drug resistance; FT-IR spectroscopy; Negative therapeutic reaction; Alkylating agent; Purine nucleoside; Cytotoxicity; Malignant hemopathy; Lymphoproliferative syndrome; cladribine (2-chlorodeoxyadenosine); Spectrométrie FT-IR; Leucémie lymphoïde; chlorambucil; Résistance traitement; Purine nucléoside; Agent alkylant; Cytotoxicité; Hémopathie maligne; Lymphoprolifératif syndrome |
|---|
| Abstract | The drug resistance of leukemic cells from 21 patients with chronic lymphocytic leukemia (CLL) to the alkylating agent chlorambucil (CLB) and the nucleoside analog cladribine or 2-chlorodeoxyadenosine (CdA) was investigated by infrared spectroscopy. Drug sensitivities, determined in vitro with the tetrazolium dye (MTT) assay, were correlated with the infrared spectra of the CLL cells, applying linear discriminant analysis (LDA). The 63 spectra (three from each of the 21 samples), obtained before drug exposure, were successfully partitioned into drug-sensitive and drug-resistant groups; the LDA-based ex vivo prediction of the sensitivity to CdA or CLB was 85.7% and 80.3%, respectively. Similar changes in the composition/structure of DNA were observed between the spectra of the drug-sensitive and drug-resistant CLL cells for both CdA and CLB. However, CdA-resistant CLL cells could also be differentiated from CdA-sensitive CLL cells by spectral changes associated with membrane lipids; these differences were much less pronounced between CLB-resistant and CLB-sensitive CLL cells. We demonstrate here for the first time that infrared spectroscopy can be used as a new tool for predicting ex vivo drug response (sensitivity/resistance). |
|---|
| Publication date | 1997-11 |
|---|
| Terms of use | - You may reproduce (print, make photocopies, or download) materials from NPArC without permission for non-commercial purposes (research, education, and private study), on the condition that you provide proper attribution of the sources in all copies.
|
|---|
| Access condition | |
|---|
| In | |
|---|
| Language | English |
|---|
| Peer reviewed | Yes |
|---|
| NRC number | 498 |
|---|
| NPARC number | 9201848 |
|---|
| Export citation | Export as RIS |
|---|
| Report a correction | Report a correction (opens in a new tab) |
|---|
| Record identifier | d8338c03-b26d-4541-b21c-211f7ffbe8d5 |
|---|
| Record created | 2009-10-02 |
|---|
| Record modified | 2020-03-20 |
|---|
